Dimensional Fund Advisors LP acquired a new position in Cantel Medical Corp. (NYSE:CMD) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 972,355 shares of the company’s stock, valued at approximately $75,756,000. Dimensional Fund Advisors LP owned about 2.34% of Cantel Medical Corp. as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of the business. Principal Financial Group Inc. bought a new stake in shares of Cantel Medical Corp. during the 2nd quarter valued at $21,919,000. Rhumbline Advisers bought a new stake in shares of Cantel Medical Corp. during the 2nd quarter valued at $5,892,000. Bank of New York Mellon Corp bought a new stake in shares of Cantel Medical Corp. during the 2nd quarter valued at $38,718,000. Kennedy Capital Management Inc. bought a new stake in shares of Cantel Medical Corp. during the 2nd quarter valued at $6,666,000. Finally, Legal & General Group Plc purchased a new position in shares of Cantel Medical Corp. during the 2nd quarter valued at $5,439,000. 83.83% of the stock is owned by institutional investors and hedge funds.
CMD has been the topic of a number of analyst reports. Sidoti upgraded shares of Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 target price on the stock in a research note on Wednesday, August 2nd. Zacks Investment Research upgraded shares of Cantel Medical Corp. from a “hold” rating to a “buy” rating and set a $83.00 target price on the stock in a research note on Tuesday, August 1st. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cantel Medical Corp. in a research note on Friday, September 1st. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $91.67.
In other Cantel Medical Corp. news, Director Mark N. Diker sold 7,000 shares of the stock in a transaction that occurred on Tuesday, October 3rd. The shares were sold at an average price of $98.90, for a total value of $692,300.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director George L. Fotiades sold 6,000 shares of the firm’s stock in a transaction that occurred on Friday, October 13th. The stock was sold at an average price of $95.23, for a total transaction of $571,380.00. The disclosure for this sale can be found here. Insiders sold 33,500 shares of company stock valued at $3,296,255 in the last ninety days. 14.90% of the stock is owned by corporate insiders.
Cantel Medical Corp. (NYSE:CMD) opened at 95.42 on Wednesday. The company’s 50-day moving average is $87.86 and its 200 day moving average is $78.49. Cantel Medical Corp. has a one year low of $68.19 and a one year high of $99.83. The company has a market capitalization of $3.96 billion, a P/E ratio of 55.80 and a beta of 1.25.
Cantel Medical Corp. (NYSE:CMD) last announced its quarterly earnings data on Thursday, September 28th. The company reported $0.54 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.02. Cantel Medical Corp. had a net margin of 9.27% and a return on equity of 17.60%. The business had revenue of $205.50 million for the quarter, compared to analyst estimates of $200.32 million. Cantel Medical Corp.’s revenue was up 14.8% on a year-over-year basis. On average, equities analysts anticipate that Cantel Medical Corp. will post $2.34 earnings per share for the current year.
Cantel Medical Corp. Profile
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with our FREE daily email newsletter.